Clinical Trials

LymphoidOther hematologic neoplasm

Leukemia, Large Granular Lymphocytic, Lymphoma, Extranodal NK-T-Cell

NCT05774028 2023-03-17

Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride and Dexamethasone (P-GEMD) in the Treatment of Untreated Early Non-upper Respiratory Tract or Advanced Extranodal NK/T-cell Lymphoma

50 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT03671850 2022-04-29

VT-EBV-N for Treatment of Severe in EBV Positive Extranodal NK/T Cell Lymphoma Patients

48 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT05254899 2022-02-24

Anti-PD-1 Antibody and P-GEMOX Chemotherapy Combined With Radiotherapy in High-risk Early-Stage ENKTL

54 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT05149170 2021-12-08

Radiotherapy and Anti-PD-1 in Low-risk ES-ENKTCL

Lymphoma, Extranodal NK-T-Cell

NCT03439501 2021-09-24

Avelumab in Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma[AVENT STUDY]

21 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT05008666 2021-08-17

Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLH

37 enrolled

LymphoidMyeloid

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

NCT04917250 2021-06-08

GPED for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma

15 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT04899414 2021-05-24

Dexamethasone, Azacytidine,Pegaspargase and Tislelizumab for NK/T Cell Lymphoma

50 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT04676789 2020-12-21

SPENT

Lymphoma, Extranodal NK-T-Cell

NCT02544425 2020-10-22

VIDL+ASCT

27 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT03363555 2020-06-18

SHR-1210 in Patients With Relapsed or Refractory Extranodal NK/T Cell Lymphoma

97 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT04405375 2020-05-28

GPED Regimen for Relapsed/Refractory or Advanced ENKTCL

29 enrolled

LymphoidMyeloid

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

NCT04279379 2020-05-07

Sintilimab and Decitabine for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma

Lymphoma, Extranodal NK-T-Cell

NCT04338282 2020-04-08

Maintenance Therapy With Anti-PD-1 Antibody for Patients With NK/T-cell Lymphoma

Lymphoma, Extranodal NK-T-Cell

NCT04337593 2020-04-07

Combination of Basiliximab and Pegaspargase in the Treatment of ENKTCL

Lymphoma, Extranodal NK-T-Cell

NCT04096690 2020-03-11

Anti-PD-1 Antibody Combined With Pegaspargase in the Treatment of Advanced Stage NK/T-cell Lymphoma

22 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT03776279 2018-12-14

A Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral T-cell Lymphoma and NK/T-cell Lymphoma

106 enrolled

Recurrence, Lymphoma, Extranodal NK-T-Cell

NCT03701022 2018-10-09

PD1 Combined With Apatinib in Patients With Relapsed or Refractory NK/T Cell Lymphoma

61 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT03598959 2018-07-26

Tofacitinib Combined With Chidamide in R/R ENKTCL

Lymphoma, Extranodal NK-T-Cell

NCT02560441 2018-01-03

Trial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

Lymphoma, Extranodal NK-T-Cell

NCT03154918 2017-11-08

GLIDE Regimen Followed by ASCT for Aggressive NK/T Cell Lymphoma

60 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT03107962 2017-04-11

Treatment of Relapsed or Refractory Natural Killer/T Cell Lymphoma

Lymphoma, Extranodal NK-T-Cell

NCT02878278 2016-08-25

Differences Between Chidamide Taken Daily and Twice a Week in Therapeutic Effect，Pharmacokinetics, Pharmacodynamics and EB Virus Activation

24 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT01991158 2016-06-14

GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell Lymphoma

Lymphoma, Extranodal NK-T-Cell

NCT02080234 2016-04-20

Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTL

40 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT02229682 2014-09-30

Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX Chemotherapy

40 enrolled

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Extranodal NK-T-Cell

NCT01933282 2013-12-24

MTN

100 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT01921790 2013-08-22

Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma

Lymphoma, Extranodal NK-T-Cell

NCT01667302 2013-03-05

Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma

Lymphoma, Extranodal NK-T-Cell

NCT00933673 2012-02-20

New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma

76 enrolled

Lymphoma, Lymphoma, Extranodal NK-T-Cell

NCT00568607 2010-09-08

Study on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell Lymphoma

60 enrolled

Lymphoma, Lymphoma, Extranodal NK-T-Cell

NCT00740467 2010-01-28

Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders